Creation of CRAMs database: ROW2 Technologies has acquired the knowledge on Indian CRAMs industry through its efforts in serving this industry for the past six years and has created a proprietary database on Indian CRAMs. This proprietary database has two sections – a) “Qualified network” and b) Non Qualified Network.
Enrichment of CRAMs database: ROW2’s expert team further enriched this database by gathering information on various critical parameters like cGMP, FDA accreditations, turnover, R&D capabilities etc, using primary sources.
Network of Qualified CRAMs: ROW2 defined certain qualifying standards based on cGMP/ FDA accreditations, Turnover, Commercial Scale up facilities, Financial Details, Experience of working with other MNCs, In-house R&D Capabilities etc.
ROW2 then created its own network of “Qualified” CRAMs. “Qualified” CRAMs companies are those companies who satisfy some basic criteria and who have permitted ROW2 Technologies to display their strengths to any European or US companies aiming at partnering with Indian companies, after taking due prior permissions from the Indian Companies. Non Qualified Companies are those Companies who do not satisfy the basic criteria OR ROW2 Technologies does not have enough information about these companies to qualify them further.
Updation of CRAMs database: ROW2’s expert team continuously updates and expands this database using various channels and information sources. Few of them are listed below:
- Regularly visits & exhibits in all Chemical & Pharmaceutical events
- Advertises in widely read Chemical Magazines in India
- Visits companies all over India frequently
- Approaches companies registering on ROW2 Website
- Through the process of updating information in our proprietary database- SmartChem
- Keeps in constant touch with top level executives & decision making authorities of the companies in our CRAMs database to ensure updated information from these companies
|
.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
.
